2ank: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2ank.png|left|200px]] | [[Image:2ank.png|left|200px]] | ||
{{STRUCTURE_2ank| PDB=2ank | SCENE= }} | {{STRUCTURE_2ank| PDB=2ank | SCENE= }} | ||
===orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide=== | ===orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide=== | ||
{{ABSTRACT_PUBMED_16460939}} | {{ABSTRACT_PUBMED_16460939}} | ||
==About this Structure== | ==About this Structure== | ||
[[2ank]] is a 3 chain structure of [[Thrombin]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2ANK OCA]. | |||
==See Also== | |||
*[[Thrombin|Thrombin]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:016460939</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Thrombin]] | [[Category: Thrombin]] | ||
| Line 34: | Line 25: | ||
[[Category: Blood clotting]] | [[Category: Blood clotting]] | ||
[[Category: Hydrolase]] | [[Category: Hydrolase]] | ||
[[Category: Hydrolase-hydrolase inhibitor complex]] | |||
[[Category: Serine protease]] | [[Category: Serine protease]] | ||
Revision as of 10:29, 27 July 2012
orally active thrombin inhibitors in complex with thrombin and an exosite decapeptideorally active thrombin inhibitors in complex with thrombin and an exosite decapeptide
Template:ABSTRACT PUBMED 16460939
About this StructureAbout this Structure
2ank is a 3 chain structure of Thrombin with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Lange UE, Baucke D, Hornberger W, Mack H, Seitz W, Hoffken HW. Orally active thrombin inhibitors. Part 2: optimization of the P2-moiety. Bioorg Med Chem Lett. 2006 May 15;16(10):2648-53. Epub 2006 Feb 3. PMID:16460939 doi:http://dx.doi.org/10.1016/j.bmcl.2006.01.046